期刊
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 150, 期 3, 页码 721-+出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2022.03.024
关键词
Regulator of G protein signaling; G protein-coupled receptors; airway hyperresponsiveness; bronchoconstriction; asthma exacerbations; genomics; genotype; airway smooth muscle; phenotype; endotype
资金
- National Heart, Lung, and Blood Institute center [U10 HL109172, U10 HL109168, U10 HL109152, U10 HL109257, U10 HL109146, U10 HL109250, U10 HL109164, U10 HL109086, UL1 TR001102, UL1 TR000427, UL1 TR001420, UL1 TR002378]
- ALA (American Lung Association) /AAAAI (American Academy of Allergy [K23AI125785]
- Asthma & Immunology) Allergic Respiratory Diseases Research Award [AI-835475]
- USF Creative Scholarship [HL045967, R01HL142992]
RGS2 promoter variation enhances bronchoconstrictive stimulation in human airway smooth muscle and is associated with asthma severity.
Background: Regulator of G protein signaling (RGS) 2 terminates bronchoconstrictive G alpha q signaling; murine RGS2 knockout demonstrate airway hyperresponsiveness. While RGS2 promoter variants rs2746071 and rs2746072 associate with a clinical mild asthma phenotype, their impact on human airway smooth muscle (HASM) contractility and asthma severity outcomes is unknown. Objective: We sought to determine whether reductions in RGS2 expression seen with these 2 RGS2 promoter variants augment HASM contractility and associate with an asthma severity phenotype. Methods: We transfected HASM with a range of RGS2-specific small interfering RNA (siRNA) concentrations and determined RGS2 protein expression by Western blot analysis and intracellular calcium flux induced by histamine (a G alpha q-coupled H1 receptor bronchoconstrictive agonist). We conducted regression-based genotype association analyses of RGS2 variants from 611 patients from the National Heart, Lung, and Blood Institute Severe Asthma Research Program 3. Results: RGS2-specific siRNA caused dose-dependent increases in histamine-stimulated bronchoconstrictive intracellular calcium signaling (2-way ANOVA, P < .0001) with a concomitant decrease in RGS2 protein expression. RGS2-specific siRNA did not affect G alpha q-independent ionomycin-induced intracellular calcium signaling (P = .42). The minor allele frequency of rs2746071 and rs2746072 was 0.46 and 0.28 among African American/non-Hispanic Black patients and was 0.28 and 0.27 among non-Hispanic White patients, among whom these single nucleotide polymorphisms were in stronger linkage disequilibrium (r(2) = 0.97). Among non-Hispanic White patients, risk allele homozygotes for rs2746072 and rs2746071 each had nearly 2-fold greater asthma exacerbation rates relative to alternative genotypes with wild-type alleles (P-additive = 2.86 x 10(-5)/P-recessive = 5.22 x 10(-6) and P-additive = 3.46 x 10(-6)/P-recessive = 6.74 x 10(-7), respectively) at baseline, which was confirmed by prospective longitudinal exacerbation data. Conclusion: RGS2 promoter variation associates with a molecular and clinical phenotype characterized by enhanced bronchoconstrictive stimulation in vitro and higher asthma exacerbations rates in non-Hispanic White patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据